<?xml version="1.0" encoding="UTF-8"?>
<p>However, Health Canada notified healthcare providers that severe cases of drug-induced liver injuries had been reported in patients treated with tocilizumab, including cases of acute liver failure that required a transplant [
 <xref rid="B92-pharmaceuticals-13-00096" ref-type="bibr">92</xref>]. Patients should be closely monitored for the emergence of signs and symptoms of infection during and after treatment with tocilizumab, including the potential development of tuberculosis in patients who have tested negative for latent tuberculosis infection before starting therapy. Many patients who acquired these infections were taking concomitant immunosuppressants, such as methotrexate or corticosteroids, and, as such, the drug should be only used according to the specialist instructions [
 <xref rid="B93-pharmaceuticals-13-00096" ref-type="bibr">93</xref>].
</p>
